Skip to main content

Table 6 Effect of embolic agent on uterine volume, diameter of largest fibroid, infarction rate and uterine artery patency

From: Randomised trial of two embolic agents for uterine artery embolisation for fibroids: Gelfoam versus Embospheres (RAGE trial)

 

Embospheres

Gelfoam

Difference between groups (E-G)***

Baseline*

6 months*

Change**

Baseline*

6 months*

Change**

Uterine volume (cc)

1018 (666)

622 (436)

− 257 (− 398 to − 115) p = 0.001

1026 (756)

908 (720)

− 117 (− 286 to 52) p = 0.15

−281 (− 496 to − 66) p = 0.01

Largest fibroid diameter (cm)

9.2 (3.8)

7.3 (3.4)

− 2.0 (− 3.0 to − 1.0)

p = 0.002

9.5 (4.8)

8.8 (5.9)

−0.7 (− 1.9 to 0.5)

p = 0.20

−1.3 (− 2.7 to 0.2) p = 0.09

Uterine artery

 

10 (100%)

  

10 (10%)

  

Complete infarction (100%)

 

5 (50%)

  

2 (20%)

  

Almost complete infarction (99–90%) 99–90%)

 

3 (30%)

  

1 (10%)

  

Incomplete infarction (< 90%)

 

2 (20%)

  

7 (70%)

  
  1. *Mean (SD)
  2. **Mean of change over time calculated as 6 month – baseline, 95% CI of change, p-value
  3. ***Mean difference between embolic agents at 6 months adjusted for baseline values, 95% CI of difference. Positive values indicate higher results in the E group